1 citations
,
November 2020 in “International Journal of Dermatology” In this case report, the authors suggest that methotrexate-induced rheumatoid papular eruption is a rare side effect of methotrexate, resolved after discontinuation, which may be linked to rheumatic conditions.
November 2023 in “Clinical, Cosmetic and Investigational Dermatology” This case report identified a maculopapular rash in a 76-year-old male, occurring 2 months after starting Finasteride for prostatic hyperplasia, with clinical and histologic evidence suggesting a drug-induced skin eruption.
July 2023 in “The Journal of Family Practice” This case study describes a 29-year-old man who presented with a fever and a generalized maculopapular rash, alongside symptoms like hair loss and joint pain, leading to an investigation into whether his condition was a case of the "great masquerader.
December 2013 in “American journal of transplantation” This case report describes a 27-year-old kidney transplant recipient with end stage renal failure who developed infections and adverse reactions, ultimately resolving with antiviral treatment targeting HHV6.
176 citations
,
May 2020 in “Dermatologic Therapy” This review discusses the cutaneous symptoms associated with COVID-19 and their potential use in diagnosing and assessing the severity of the disease, but it reports no new clinical results.
101 citations
,
July 2020 in “Dermatologic therapy” This systematic review reports that "COVID toes" and other skin manifestations can be initial signs of COVID-19, and advises immunosuppressive therapy adjustments only for infected or at-risk patients.
82 citations
,
March 2013 in “PLoS ONE” In this study, vemurafenib was associated with a wide range of cutaneous side effects in patients with advanced melanoma, including photosensitivity and various skin and hair changes, necessitating regular dermatological management.
64 citations
,
February 1995 in “Journal of The American Academy of Dermatology” This report describes a case where hidradenitis suppurativa developed in a patient receiving lithium, adding to the recognized cutaneous side effects like psoriasis, acneiform lesions, and alopecia.
12 citations
,
May 2015 in “Journal of the National Comprehensive Cancer Network” This article provides a narrative on managing dermatologic side effects from cancer therapies and suggests strategies that oncologists could adopt, but it reports no new clinical findings.
10 citations
,
January 2021 in “BioMed Research International” This study found that patients who recovered from COVID-19 experienced various skin, hair, and nail issues, with hair shedding being more common in those with moderate to severe cases.
8 citations
,
June 2021 in “Journal of Cosmetic Dermatology” This review details various skin manifestations linked to COVID-19 and highlights dermatitides caused by personal protective equipment, emphasizing the need for accurate diagnosis and prompt treatment.
7 citations
,
May 2022 in “Skin health and disease” This study found that COVID-19 is associated with various skin rashes, which can indicate the severity of the disease, with chilblain-like lesions linked to milder cases and acro-ischaemia to more severe outcomes.
7 citations
,
January 2021 in “Biology” This study documented a variety of skin lesions in COVID-19 patients, indicating that skin rashes might be an early or sole symptom of the disease.
4 citations
,
October 2013 in “PLoS ONE” This study found that Vemurafenib led to a broad range of cutaneous side effects in nearly all patients with advanced melanoma, highlighting the need for regular dermatologic management and UV protection.
2 citations
,
September 2021 This review discusses the role of teledermatology during the COVID-19 pandemic, highlighting the practical challenges and opportunities in diagnosing skin diseases in low-income countries, and reports no new clinical results.
2 citations
,
March 2017 in “TURKDERM” This study observed that pediatric bone marrow transplantation patients frequently experience various dermatological issues; mucositis and xeroderma were the most common.
1 citations
,
December 2023 in “Revista médica de Chile” This review examines the dermatologic side effects of lithium, noting it can cause or worsen skin conditions like psoriasis and acne, potentially affecting medication adherence, but reports no new clinical results.
1 citations
,
July 2022 in “BMJ Case Reports” This case report describes a woman in her 30s diagnosed with systemic lupus erythematosus, characterized by alopecia, arthritis, photosensitivity, and skin rashes, confirmed through positive serology.
1 citations
,
November 2020 in “Cermin Dunia Kedokteran” This article discusses the range of skin manifestations associated with COVID-19, which may assist clinicians in early diagnosis, but it reports no new clinical results.
September 2022 in “Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica” This review discusses mucocutaneous manifestations associated with Covid-19, classifies the lesions, and describes their characteristics and treatments but reports no new clinical findings.
This article explores various skin reactions linked to COVID-19, including "COVID toes" and other rashes, which tend to appear in mild cases, while severe conditions like livedo reticularis are more often seen in critically ill patients, according to medical experts.
February 2026 in “Cureus” This study reported that chemotherapy-induced skin reactions in cancer patients are mostly mild to moderate and manageable with supportive care, suggesting that early dermatologic intervention can improve patient outcomes without interrupting chemotherapy.
August 2024 in “Journal of Research in Clinical Medicine” In this study, researchers observed that patients with COVID-19 can develop a variety of skin lesions, with maculopapular rash, telogen effluvium, and urticaria showing significant associations with both the timing of symptom onset and the severity of the disease.
This article reviews the cutaneous side effects of immune checkpoint inhibitors and targeted therapies for skin cancers, noting that while generally mild, these effects can influence treatment decisions and quality of life, underscoring the need for physicians to be aware of these adverse reactions.
June 2023 in “Institutional Repositories DataBase (IRDB)” In this study, researchers observed six patterns of skin reactions in COVID-19 patients and noted potential skin responses following vaccination, although the mechanisms remain unclear.
May 2023 in “Dermatology Reports” In this original study, researchers documented 121 COVID-19 cases with a wide range of mucocutaneous manifestations, some linked to internal organ damage and others to new vaccine-associated dermatoses, emphasizing the importance of rapid diagnosis to prevent potentially life-threatening systemic events.
May 2022 in “Голова и шея.” This report describes a case of a patient with metastatic renal cell carcinoma who developed a psoriasiform skin lesion while undergoing immune checkpoint inhibitor therapy.
March 2022 in “Journal of Clinical Case Studies Reviews & Reports” COVID-19 can cause or worsen skin conditions and might show early signs of infection.
January 2022 in “Indian Journal of Psychiatry/Indian journal of psychiatry” This case report describes a patient who developed a maculopapular rash after starting lithium treatment, highlighting the importance of monitoring skin reactions due to potential impact on treatment adherence.
December 2021 in “The Sri Lanka Journal of Dermatology” This study found that the prevalence of dermatological manifestations in COVID-19 patients was 1.7% in Sri Lanka, with various types of skin lesions reported.